The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications Botox and Trulicity. This third cycle of negotiations is the first to include drugs payable under Medicare Part B, which are traditionally administered in clinical settings, in addition…
You may also like
American Academy of Pediatrics departs from CDC with childhood vaccine revisions
The American Academy of Pediatrics (AAP) has once again diverged from recent federal vaccine guidance, ...
Chair of CDC’s vaccine panel questions need for polio vaccines, citing personal autonomy
Kirk Milhoan, a pediatric cardiologist recently appointed as chair of a highly influential federal vaccine ...